串联质谱联合人工智能诊断新生儿甲基丙二酸血症的准确率及影响因素分析

闫鹏跃, 于洋, 姜珊, 李红伟, 吴红丽

中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (4) : 464-469.

PDF(565 KB)
HTML
PDF(565 KB)
HTML
中国当代儿科杂志 ›› 2026, Vol. 28 ›› Issue (4) : 464-469. DOI: 10.7499/j.issn.1008-8830.2509094
论著·临床研究

串联质谱联合人工智能诊断新生儿甲基丙二酸血症的准确率及影响因素分析

作者信息 +

Diagnostic accuracy of tandem mass spectrometry combined with artificial intelligence for neonatal methylmalonic acidemia and associated factors

Author information +
文章历史 +

摘要

目的 探究串联质谱(tandem mass spectrometry, MS/MS)联合人工智能(artificial intelligence, AI)技术对新生儿甲基丙二酸血症(methylmalonic acidemia, MMA)的诊断准确率,并分析影响诊断准确性的因素。 方法 召回秦皇岛市妇幼保健院2019年1月—2024年12月间MMA初筛结果阳性的新生儿246例进行复查。以基因诊断为金标准,对所有患儿进行MS/MS诊断、AI诊断和联合诊断(MS/MS联合AI),评估不同诊断方法的灵敏度、特异度等诊断效能指标,同时分析其与基因诊断的一致性,并采用多因素logistic回归分析诊断准确性的影响因素。 结果 联合诊断的灵敏度为92.3%,特异度为97.0%,准确率为96.7%,与基因诊断的一致性高(Kappa=0.733)。联合诊断、MS/MS诊断和AI诊断的曲线下面积分别为0.914(95%CI:0.867~0.935)、0.759(95%CI:0.635~0.816)和0.669(95%CI:0.584~0.776),联合诊断的曲线下面积大于MS/MS诊断、AI诊断(P<0.05)。甲硫氨酸、苯丙氨酸、鸟氨酸、甘氨酸、血氨、乳酸水平低,以及电生理检查结果异常均是影响诊断准确性的因素(P<0.05)。 结论 MS/MS联合AI诊断对新生儿MMA的诊断准确率较高;甲硫氨酸、苯丙氨酸、鸟氨酸、甘氨酸、血氨、乳酸水平低,以及电生理检查结果异常可影响MMA诊断的准确性。

Abstract

Objective To evaluate the diagnostic accuracy of tandem mass spectrometry (MS/MS) combined with artificial intelligence (AI) for neonatal methylmalonic acidemia (MMA), and to identify factors associated with diagnostic accuracy. Methods A total of 246 neonates with positive initial MMA screening at Qinhuangdao Maternal and Child Health Hospital from January 2019 to December 2024 were recalled for confirmatory testing. Using genetic diagnosis as the reference standard, all cases underwent MS/MS diagnosis, AI diagnosis, and combined diagnosis (MS/MS plus AI). Sensitivity, specificity, accuracy, and other diagnostic performance indices were calculated; agreement with genetic diagnosis was assessed; and multivariable logistic regression was performed to identify factors associated with diagnostic accuracy. Results The combined diagnosis yielded a sensitivity of 92.3%, a specificity of 97.0%, and an accuracy of 96.7%, with high agreement with genetic diagnosis (Kappa=0.733). The areas under the receiver operating characteristic curve for combined, MS/MS, and AI diagnoses were 0.914(95%CI: 0.867-0.935), 0.759(95%CI: 0.635-0.816), and 0.669(95%CI: 0.584-0.776), respectively; the area under the curve for the combined diagnosis was significantly higher than that for either MS/MS or AI alone (P<0.05). Lower levels of methionine, phenylalanine, ornithine, glycine, blood ammonia, and lactic acid, as well as abnormal electrophysiological findings, were independently associated with diagnostic accuracy (P<0.05). Conclusions MS/MS combined with AI shows high diagnostic accuracy for neonatal MMA. Lower levels of methionine, phenylalanine, ornithine, glycine, blood ammonia, and lactic acid and abnormal electrophysiological findings may affect the diagnostic accuracy of MMA.

关键词

甲基丙二酸血症 / 串联质谱 / 诊断 / 准确率 / 新生儿

Key words

Methylmalonic acidemia / Tandem mass spectrometry / Diagnosis / Accuracy / Neonate

引用本文

导出引用
闫鹏跃, 于洋, 姜珊, . 串联质谱联合人工智能诊断新生儿甲基丙二酸血症的准确率及影响因素分析[J]. 中国当代儿科杂志. 2026, 28(4): 464-469 https://doi.org/10.7499/j.issn.1008-8830.2509094
Peng-Yue YAN, Yang YU, Shan JIANG, et al. Diagnostic accuracy of tandem mass spectrometry combined with artificial intelligence for neonatal methylmalonic acidemia and associated factors[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 464-469 https://doi.org/10.7499/j.issn.1008-8830.2509094

参考文献

[1]
Yamashita F, Akamine S, Chong PF, et al. Methylmalonic acidemia with recurrent hemophagocytic lymphohistiocytosis: a case report and review of the literature[J]. BMC Pediatr, 2025, 25(1): 259. PMCID: PMC11956439. DOI: 10.1186/s12887-025-05613-9 .
[2]
Keller SA, Luciani A. Mitochondrial distress in methylmalonic acidemia: novel pathogenic insights and therapeutic perspectives[J]. Cells, 2022, 11(19): 3179. PMCID: PMC9563610. DOI: 10.3390/cells11193179 .
[3]
李育霖, 孙萌, 李盼盼, 等. 新生儿甲基丙二酸血症生化筛查与基因筛查结果分析[J]. 中华实用儿科临床杂志, 2023, 38(1): 54-59. DOI: 10.3760/cma.j.cn101070-20221102-01249 .
[4]
Chen T, Gao Y, Zhang S, et al. Methylmalonic acidemia: neurodevelopment and neuroimaging[J]. Front Neurosci, 2023, 17: 1110942. PMCID: PMC9909197. DOI: 10.3389/fnins.2023.1110942 .
[5]
Head PE, Meier JL, Venditti CP. New insights into the pathophysiology of methylmalonic acidemia[J]. J Inherit Metab Dis, 2023, 46(3): 436-449. PMCID: PMC10715492. DOI: 10.1002/jimd.12617 .
[6]
Liang L, Shuai R, Yu Y, et al. A rare mutation c.1663G > A (p.A555T) in the MMUT gene associated with mild clinical and biochemical phenotypes of methylmalonic acidemia in 30 Chinese patients[J]. Orphanet J Rare Dis, 2021, 16(1): 22. PMCID: PMC7792044. DOI: 10.1186/s13023-020-01632-0 .
[7]
Baek R, Coughlan K, Jiang L, et al. Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria[J]. Nat Commun, 2024, 15(1): 3804. PMCID: PMC11076592. DOI: 10.1038/s41467-024-47460-9 .
[8]
陈重芬, 张耀东, 葛丽丽, 等. 甲基丙二酸血症伴同型半胱氨酸血症患儿65例的临床及MMACHC基因变异分析[J]. 中华医学遗传学杂志, 2023, 40(9): 1086-1092. DOI: 10.3760/cma.j.cn511374-20220621-00417 .
[9]
王文婷, 陈莲. 甲基丙二酸血症临床病理学分析[J]. 诊断病理学杂志, 2023, 30(3): 267-269. DOI: 10.3969/j.issn.1007-8096.2023.03.015 .
[10]
Reischl-Hajiabadi AT, Schnabel E, Gleich F, et al. Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias[J]. J Inherit Metab Dis, 2024, 47(4): 674-689. DOI: 10.1002/jimd.12731 .
[11]
Manoli I, Gebremariam A, McCoy S, et al. Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia[J]. J Inherit Metab Dis, 2023, 46(4): 554-572. PMCID: PMC10330948. DOI: 10.1002/jimd.12636 .
[12]
Men S, Liu S, Zheng Q, et al. Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: a 7-year study in eastern coastal areas of China[J]. Mol Genet Genomic Med, 2023, 11(6): e2152. PMCID: PMC10265071. DOI: 10.1002/mgg3.2152 .
[13]
Cafaro A, Pigliasco F, Barco S, et al. A novel LC-MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot[J]. Molecules, 2021, 26(18): 5707. PMCID: PMC8469151. DOI: 10.3390/molecules26185707 .
[14]
Mitsala A, Tsalikidis C, Pitiakoudis M, et al. Artificial intelligence in colorectal cancer screening, diagnosis and treatment. A new era[J]. Curr Oncol, 2021, 28(3): 1581-1607. PMCID: PMC8161764. DOI: 10.3390/curroncol28030149 .
[15]
Huang X, Wang H, She C, et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy[J]. Front Endocrinol (Lausanne), 2022, 13: 946915. PMCID: PMC9559815. DOI: 10.3389/fendo.2022.946915 .
[16]
Yu KH, Healey E, Leong TY, et al. Medical artificial intelligence and human values[J]. N Engl J Med, 2024, 390(20): 1895-1904. PMCID: PMC12425466. DOI: 10.1056/NEJMra2214183 .
[17]
黄国英, 王天有. 儿科学[M]. 2版. 北京: 人民卫生出版社, 2022: 997.
[18]
张潇分, 王燕敏, 周卓, 等. 串联质谱法和高效液相色谱-串联质谱法及气相色谱质谱法联合诊断甲基丙二酸血症的价值[J]. 中华实用诊断与治疗杂志, 2024, 38(11): 1154-1158. DOI: 10.13507/j.issn.1674-3474.2024.11.014 .
[19]
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30 .
[20]
汪治华, 刘超, 李玛丽. 甲基丙二酸血症的诊治现状与展望[J]. 中国实用儿科杂志, 2024, 39(12): 911-915. DOI: 10.19538/j.ek2024120606 .
[21]
Jin L, Han X, He F, et al. Prevalence of methylmalonic acidemia among newborns and the clinical-suspected population: a meta-analyse[J]. J Matern Fetal Neonatal Med, 2022, 35(25): 8952-8967. DOI: 10.1080/14767058.2021.2008351 .
[22]
Martín-Rivada Á, Palomino Pérez L, Ruiz-Sala P, et al. Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region[J]. JIMD Rep, 2022, 63(2): 146-161. PMCID: PMC8898721. DOI: 10.1002/jmd2.12265 .
[23]
Forny P, Hörster F, Ballhausen D, et al. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision[J]. J Inherit Metab Dis, 2021, 44(3): 566-592. PMCID: PMC8252715. DOI: 10.1002/jimd.12370 .
[24]
赵玲玉, 陈振贺, 王也, 等. 探针电喷雾离子化质谱法结合人工智能建立肺腺癌术中良恶性快速诊断模型[J]. 中日友好医院学报, 2024, 38(4): 209-212. DOI: 10.3969/j.issn.1001-0025.2024.04.004 .
[25]
Yin Z, Zhang C, Dong R, et al. Improving methylmalonic acidemia (MMA) screening and MMA genotype prediction using random forest classifier in two Chinese populations[J]. Eur J Med Res, 2024, 29(1): 540. PMCID: PMC11552112. DOI: 10.1186/s40001-024-02115-9 .
[26]
Arhip L, Brox-Torrecilla N, Romero I, et al. Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review[J]. Orphanet J Rare Dis, 2024, 19(1): 20. PMCID: PMC10799514. DOI: 10.1186/s13023-024-03021-3 .
[27]
Haijes HA, Jans JJM, van der Ham M, et al. Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach[J]. Orphanet J Rare Dis, 2020, 15(1): 68. PMCID: PMC7060614. DOI: 10.1186/s13023-020-1347-3 .
[28]
Yu Y, Shuai R, Liang L, et al. Different mutations in the MMUT gene are associated with the effect of vitamin B12 in a cohort of 266 Chinese patients with mut-type methylmalonic acidemia: a retrospective study[J]. Mol Genet Genomic Med, 2021, 9(11): e1822. PMCID: PMC8606212. DOI: 10.1002/mgg3.1822 .
[29]
Head PE, Myung S, Chen Y, et al. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin[J]. Sci Transl Med, 2022, 14(646): eabn4772. PMCID: PMC10468269. DOI: 10.1126/scitranslmed.abn4772 .

脚注

所有作者均声明无利益冲突。

基金

秦皇岛市科学技术研究与发展计划项目(202401A026)

版权

版权所有 © 2023中国当代儿科杂志
PDF(565 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/